PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för MST-312. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

21 hits

Bibliografisk träff 2024-01-22

Combinatorial targeting of telomerase and DNA-PK induces synergistic apoptotic effects against Pre-B acute lymphoblastic leukemia cells.

Katoueezadeh M, Maleki P, Torabizadeh SA, Farsinejad A, Khalilabadi RM, Valandani HM, Nurain IO, Ashoub MH, Fatemi A.

Mol Biol Rep · journal article · DOI 10.1007/s11033-023-09087-9

Bibliografisk träff 2024-01-10

Role of p53 transcription factor in determining the efficacy of telomerase inhibitors in cancer treatment.

Gala K, Jain M, Shah P, Pandey A, Garg M, Khattar E.

Life Sci · journal article · DOI 10.1016/j.lfs.2024.122416

Bibliografisk träff 2023-09-12

Telomerase Inhibition by MST-312 Sensitizes Breast Cancer Cells to the Anti-cancer Properties of Plumbagin.

Sameni S, Viswanathan R, Ng GY, Martinez-Lopez W, Hande MP.

Genome Integr · research-article; journal article · DOI 10.14293/genint.14.1.003

Bibliografisk träff 2022-11-15

Drug Repositioning Identifies Six Drug Candidates for Systemic Autoimmune Diseases by Integrative Analyses of Transcriptomes from Scleroderma, Systemic Lupus Erythematosus, and Sjogren's Syndrome.

Oktem EK, Yazar M.

OMICS · journal article · DOI 10.1089/omi.2022.0138

Bibliografisk träff 2022-10-21

Telomerase inhibitor MST-312 and quercetin synergistically inhibit cancer cell proliferation by promoting DNA damage.

Fernandes SG, Gala K, Khattar E.

Transl Oncol · brief-report; journal article · DOI 10.1016/j.tranon.2022.101569

Bibliografisk träff 2022-07-10

Effects of long-term exposure to MST-312 on lung cancer cells tumorigenesis: Role of SHH/GLI-1 axis.

Villarinho NJ, Vasconcelos FDC, Mazzoccoli L, da Silva Robaina MC, Pessoa LS, Siqueira PET, Maia RC, de Oliveira DM, Leite de Sampaio E Spohr TC, Lopes GF.

Cell Biol Int · journal article · DOI 10.1002/cbin.11843

Bibliografisk träff 2022-01-02

Evaluation of the efficacy of MST-312, as a telomerase inhibitor, in the treatment of patients with multiple myeloma after stem cell transplantation.

Zhou C, Liu S.

Cell Mol Biol (Noisy-le-grand) · journal article · DOI 10.14715/cmb/2021.67.4.13

Bibliografisk träff 2021-04-22

A Bioinformatics Analysis Identifies the Telomerase Inhibitor MST-312 for Treating High-STMN1-Expressing Hepatocellular Carcinoma.

Wang SJ, Yang PM.

J Pers Med · research-article; journal article · DOI 10.3390/jpm11050332

Bibliografisk träff 2021-01-01

Effects of in vitro short- and long-term treatment with telomerase inhibitor in U-251 glioma cells.

Andrade da Mota TH, Reis Guimarães AF, Silva de Carvalho AÉ, Saldanha-de Araujo F, Pinto de Faria Lopes G, Pittella-Silva F, do Amaral Rabello D, Madureira de Oliveira D.

Tumour Biol · journal article · DOI 10.3233/tub-211515

Bibliografisk träff 2019-12-04

Spheroid-Derived Cells From Renal Adenocarcinoma Have Low Telomerase Activity and High Stem-Like and Invasive Characteristics.

Saeednejad Zanjani L, Madjd Z, Rasti A, Asgari M, Abolhasani M, Tam KJ, Roudi R, Mælandsmo GM, Fodstad Ø, Andersson Y.

Front Oncol · research-article; journal article · DOI 10.3389/fonc.2019.01302

Bibliografisk träff 2019-04-25

Telomerase inhibitor MST-312 induces apoptosis of multiple myeloma cells and down-regulation of anti-apoptotic, proliferative and inflammatory genes.

Ameri Z, Ghiasi S, Farsinejad A, Hassanshahi G, Ehsan M, Fatemi A.

Life Sci · journal article · DOI 10.1016/j.lfs.2019.04.060

Bibliografisk träff 2019-04-23

Long-term in vitro treatment with telomerase inhibitor MST-312 induces resistance by selecting long telomeres cells.

Morais KDS, Arcanjo DDS, de Faria Lopes GP, da Silva GG, da Mota THA, Gabriel TR, Rabello Ramos DDA, Silva FP, de Oliveira DM.

Cell Biochem Funct · journal article · DOI 10.1002/cbf.3398

Bibliografisk träff 2018-07-30

The telomerase inhibitor MST-312 synergistically enhances the apoptotic effect of doxorubicin in pre-B acute lymphoblastic leukemia cells.

Ghasemimehr N, Farsinejad A, Mirzaee Khalilabadi R, Yazdani Z, Fatemi A.

Biomed Pharmacother · journal article · DOI 10.1016/j.biopha.2018.07.140

Bibliografisk träff 2018-03-28

Herpes simplex virus virucidal activity of MST-312 and epigallocatechin gallate.

Pradhan P, Nguyen ML.

Virus Res · research support, non-u.s. gov't; journal article · DOI 10.1016/j.virusres.2018.03.015

Bibliografisk träff 2017-08-01

Long-term exposure to MST-312 leads to telomerase reverse transcriptase overexpression in MCF-7 breast cancer cells.

Morais KS, Guimarãesb AFR, Ramos DAR, Silva FP, de Oliveira DM.

Anticancer Drugs · research support, non-u.s. gov't; journal article · DOI 10.1097/cad.0000000000000508

Bibliografisk träff 2016-05-31

Combination treatment with flavonoid morin and telomerase inhibitor MST‑312 reduces cancer stem cell traits by targeting STAT3 and telomerase.

Chung SS, Oliva B, Dwabe S, Vadgama JV.

Int J Oncol · research-article; journal article · DOI 10.3892/ijo.2016.3546

Bibliografisk träff 2015-07-15

The Telomerase Inhibitor MST-312 Interferes with Multiple Steps in the Herpes Simplex Virus Life Cycle.

Haberichter J, Roberts S, Abbasi I, Dedthanou P, Pradhan P, Nguyen ML.

J Virol · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/jvi.01006-15

Bibliografisk träff 2015-05-29

MST-312 induces G2/M cell cycle arrest and apoptosis in APL cells through inhibition of telomerase activity and suppression of NF-κB pathway.

Fatemi A, Safa M, Kazemi A.

Tumour Biol · research support, non-u.s. gov't; journal article · DOI 10.1007/s13277-015-3575-z

Bibliografisk träff 2015-01-13

Radiosensitization to X-ray radiation by telomerase inhibitor MST-312 in human hepatoma HepG2 cells.

Wang Y, Sun C, Mao A, Zhang X, Zhou X, Wang Z, Zhang H.

Life Sci · research support, non-u.s. gov't; journal article · DOI 10.1016/j.lfs.2014.12.027

Bibliografisk träff 2014-01-01

MST-312 Alters Telomere Dynamics, Gene Expression Profiles and Growth in Human Breast Cancer Cells.

Gurung RL, Lim SN, Low GK, Hande MP.

J Nutrigenet Nutrigenomics · research support, non-u.s. gov't; journal article · DOI 10.1159/000381346

Bibliografisk träff 2002-07-01

Telomere shortening and growth inhibition of human cancer cells by novel synthetic telomerase inhibitors MST-312, MST-295, and MST-1991.

Seimiya H, Oh-hara T, Suzuki T, Naasani I, Shimazaki T, Tsuchiya K, Tsuruo T.

Mol Cancer Ther · research support, non-u.s. gov't; journal article